Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Rheumatology Podcast

Credit(s)

1.25

AMA PRA Category 1 CreditsTM

CPE Contact Hours

CNE Contact Hours

Pre-Test

Complete the pre-quiz poll to access the course episodes. 

Prequiz Podcast | Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.

 

Faculty Relationship Identified With:
Joan T. Merrill, MD Consultant/Advisor: AbbVie Inc.; Amgen Inc.; AstraZeneca; Biogen; Boehringer Ingelheim; Bristol Myers Squibb; EMD Serono; Genetech/Roche; GSK; Janssen; Lilly; Merck MSD; RemeGen Biosciences; Sanofi; UCB; Zenas BioPharma, Inc.

Speaker: AbbVie Inc.; Biogen; Bristol Myers Squibb; EMD Serono; GSK; Merck MSD; Sanofi; Zenas BioPharma, Inc.

IST: Bristol Myers Squibb; GSK

 

Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC, Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AcademicCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM.

AcademicCME designates this enduring material for a maximum of 1.25 CNE Contact Hour.

AcademicCME designates this continuing education activity for 1.25 CPE Contact Hours (.125 CEUs) of continuing pharmacy education credit (UAN JA4008190-0000-25-032-H01-P).

Clinicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been supported by an independent educational grant from Bristol Myers Squibb.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

For all CE inquiries or special needs, please contact admin@academiccme.com.

ACCREDIDATION

Earn your Credits After Completing Podcast Episodes

Related Podcast Courses

No podcast was found